Innovative Approaches to Accelerating Drug Discovery and Development
Event Information
Description
How can we accelerate successful drug development?
The success of clinical candidate development depends on several factors, important among them are generation of novel, therapeutically-relevant chemical structures, early and rapid assessment of possible efficacy of candidate structures in pre-clinical therapeutic models and rapid elimination of candidates that will ultimately prove unsuccessful. Innovative processes and techniques that facilitate optimal candidate selection is a crucial step in accelerating drug discovery and development timelines.
BioDuro invites you to a symposium on Innovative Approaches to Accelerating Drug Discovery and Development. Join us on Thursday, March 22, 2018 for an afternoon of lunch, insightful presentations and discussion with industry experts, followed by a networking and happy hour reception.
Agenda:
11:30 PM- 12:30 PM
Registration/Lunch, Opening Remarks
12:30 PM- 5:00 PM
From Small Fragments to Big Drugs: Fragment-based Drug Discovery
Dan Erlanson, Ph.D | Co-founder and VP of Chemistry | Carmot Therapeutics
From Fragments to Drugs: Playing Quick Molecular Scrabble with Protein Crystallography
Debanu Das, Ph.D | Co-founder and CEO | AcceleroBio
Role of DMPK in Drug Discovery and Development
JP Shaw, Ph.D | Independent Pre-Clinical DMPK Consultant
Paving the Road to the Clinic: Advancing Oncology Drug Development with Translational In Vitro and In Vivo Models
Tommy Broudy, Ph.D | CEO | Molecular Response
Non-Toxic Pre-Clinical Formulations for Insoluble Compounds: Applying Enabled Formulations Approaches to Late Phase Discovery
Blair West, Ph.D | Chief Science Officer, Global CMC Solutions | BioDuro
Rapid Development and Scale-up of Solubilized Dosage Forms
Ruchit Trivedi, Ph.D | Associate Director, Formulation | BioDuro
5:00 PM- 6:00 PM
Networking Happy Hour
Contact:
hello@bioduro.com
(858) 529-6600
www.bioduro.com
